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ABSTRACT 
RIDGE AUGMENTATION COMPARING A CANCELLOUS BLOCK ALLOGRAFT 
TO FREEZE DRIED BONE PARTICLES AND UTILIZING AN ACELLULAR 
DERMAL MATRIX BARRIER MEMBRANE 
Brenton Lahey, DMD 
June 29, 2005 
Aims. The primary aim of this randomized, controlled, blinded clinical trial was to 
compare the clinical and histologic results of ridge augmentation comparing a cancellous 
block allograft to a particulate mineralized freeze dried bone allograft using acellular 
dermal matrix as a barrier membrane. 
Methods. Twenty-four patients that met the following inclusion criteria were 
sequentially entered into the study: 1) at least age 18; 2) had at least a one tooth ridge 
defect treatment planned to receive a dental implant; 3) the defect was bordered by at 
least one tooth; and 3) an IRB approved informed consent was signed. Twelve test 
patients received a freeze dried bone particulate graft packed around supporting screws 
while 12 positive control patients received a cancellous block allograft immobilized with 
1 or 2 screws. Following elevation of a superficial split -thickness flap, horizontal ridge 
dimensions were measured with a digital caliper at the crest and 5 mm apical to the crest. 
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Vertical ridge dimensions were measured from a tooth-supported stent. At 4 month re-
entry a 2.7 X 6 mm trephine core was obtained prior to implant placement. 
Results. The crestal ridge width of the particulate group increased from 4.4 ;!; 1.0 mm to 
7.7 ± 1.5 mm for a mean gain of 3.3 ± 1.1 mm (p < 0.05) while the cancellous block 
cases increased from 3.3 ± 0.9 mm to 7.1 ± 1.0 mm for a mean gain of 3.8 ± 1.3 mm (p < 
0.05). There was no significant difference between the two groups (p > 0.05). The width 
of the particulate group 5 mm apical to the crest increased from 6.9 ± 1.1 mm to 9.7 ± 1.7 
mm for a mean gain of 2.9 ± 1.0 mm (p < 0.05) while the cancellous cases increased from 
5.6 ± 1.1 mm to 9.0 ± 1.2 mm for a gain of 3.4 ± 1.0 mm (p < 0.05). There was no 
significant difference between the two groups (p > 0.05). The vertical component of the 
ridge defects was minimal, therefore, there was negligible gain of ridge height. Implants 
were placed as treatment planned in 12112 or 100% of the cancellous block cases, 
Implants were placed as treatment planned or with a larger diameter in 12112 or 100% of 
the particulate cases. Histologic analysis of the implant sites revealed 51 ± 18% vital 
bone for the cancellous block group and 58 ± 12% for the particulate group. Non-vital 
bone was 11 ± 9% for the cancellous block group and 9 ± 7% for the particulate group. 
Conclusions. There were no clinically or statistically significant ridge dimension 
differences between the particulate or cancellous block allograft groups. Histologic 
results also revealed minimal differences between groups. 
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In dentistry today there is a great demand for restoring edentulous areas with 
dental implants. Through years of clinical experience and research, along with 
improvements in dental materials, implants have become a very predictable procedure. 
However, implant placement requires an adequate amount of bone in both the horizontal 
and vertical dimensions. Through various processes including tooth extraction and 
trauma the required bone is often lost. Even if there is enough bone present to place an 
implant at a given site, it often is not in the correct location for ideal esthetic implant 
placement. Various bone regenerating techniques have been developed to help establish 
proper ridge position and dimensions. These procedures include bone grafting alone, 
distraction osteogenesis, and guided bone regeneration. 
Guided bone regeneration (GBR) refers to the use of membranes to regenerate 
bone in desired areas. The idea is based on the theory that the cells responsible for 
creating new bone migrate into the wound more slowly than cells responsible for the 
formation of connective tissue. The membrane serves as a barrier to connective tissue 
cells and results in new bone formation. 
To enhance the amount of new bone the GBR principle was combined with the 
use of bone grafts. Autogenous bone grafts had been used successfully without 
membranes to graft alveolar defects, and they became the bone graft material of choice 
for much of the early work done on guided bone regeneration. However, the downfalls 
of autogenous grafting such as donor site morbidity and limited supply forced clinicians 
and researchers to look for other grafting materials such as allografts, xenografts, and 
alloplasts. There has been a great deal of research on the different types of allografts in 
terms of bone type and graft form (Burchardt 1983, Zins and Whitaker 1983, Ozaki and 
Buchman 1998). Today many allografts materials have been proven to be just as 
effective as autogenous grafts when used for guided bone regeneration (Nevins and 
Mellonig 1992, Shanaman 1992, Nevins and Mellonig 1994). 
In addition to the bone graft material options, there are also many different types 
of membranes that can be used. The membranes generally fall into two broad categories. 
The first is non-resorbable membranes that must be removed during a subsequent surgical 
procedure. The second is resorbable membranes that are eventually infiltrated and 
broken down by the surrounding soft tissue. Each group has its own advantages and 
disadvantages, but both have been successfully used for guided bone regeneration 
procedures. 
The technique of guided bone regeneration has evolved over the past 15 years or 
so as clinicians have tried to increase its predictability. However many of the basic 
principles that were described by Dahlin et a1. (1988) still hold true today. 
Bone Graft Materials 
One of the main principles of ridge augmentation procedures is space 
maintenance (Buser et a1. 1993). The area of desired bone growth will be acted on by a 
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variety of forces within the mouth. In order for the ridge augmentation to be successful 
those forces cannot be allowed to collapse the space created for bone growth. One of the 
main downfalls of placing a membrane around an area without some sort of rigid support 
system is that it may fail to maintain its desired shape due to the forces put upon it. This 
results in less than desired bone growth. To combat this problem various titanium 
frameworks or meshworks have been added to, or used underneath the membranes. 
Another method used to combat this problem is the placement of a bone graft either 
under a membrane or by itself. The bone graft, especially in a rigid block form, can not 
only be resistant to external forces, but also offer osteoconductive, osteoinductive, and 
osteogenic properties that promote bone growth. It is generally accepted that the more 
rigid block forms offer better mechanical space maintenance properties than the 
particulate graft materials. The question could then be asked whether that makes a 
difference in terms of the amount of new bone created through a ridge augmentation 
procedure. 
A bone graft, whether allogeneic or autogenous, goes through several stages of 
healing after a ridge augmentation procedure. Urist (1976) described five stages of 
incorporation of a bone graft. 
Table 1 
Urist (1976) Stages of Bone Graft Incorporation 
Stage 1 Stage 2 Stage 3 Stage 4 Stage 5 




The first stage is an inflammatory one where the breakdown of the bone graft 
materials causes a chemotactic response. Mesenchymal cells that will differentiate into 
osteoblasts and osteoclasts migrate to the area. The second and third stages are 
characterized by osteoinduction. Urist (1976) defines osteoinduction as the process of 
differentiation of fibroblast-like migratory mesenchymal cells into osteoprogenitor cells 
on calcified tissue matrices that are demineralized in the course of resorption. The 
process of osteoinduction is mediated largely by proteins called bone morphogenic 
proteins or BMPs. Urist (1976) states that when an allograft is sterilized by autoclaving 
or irradiation the osteoinductive properties of the graft are lost. There are bone 
morphogenic proteins present in allografts (Goldberg and Stevenson 1987). It has been 
suggested that by demineralizing an allograft (demineralized freeze dried bone allograft, 
DFBDA) the bone morphogenic proteins are exposed and that leads to osteoinduction by 
the allograft. However, it is a matter of debate as to whether or not the BMPs in 
sterilized allografts lead to osteoinduction. In this study the two allografts probably have 
little osteoinductive capability, and so stages 2 and 3 graft incorporation are largely 
absent. Stage four of the incorporation process is characterized by osteoconduction, 
which refers to the ingrowth of vascular channels and bone forming cells from the host 
onto the graft tissue. Since osteoinduction plays a minor role at best in sterilized 
allografts, osteoconduction is the major component of the graft incorporation. Finally 
stage five of graft incorporation as described by Urist (1976) is predominantly a 
mechanical one where the graft acts as biomechanical support structure for bone 
remodeling. 
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While bone grafts of cancellous and cortical origin share common stages of graft 
incorporation, they have some important differences within those stages. Goldberg and 
Stevenson (1987) published a review article on allograft and autografts where they 
discuss these differences. In cancellous bone grafts the incorporation process is 
characterized by a rapid revascularization and resorption of non-vital graft material. The 
structure of the cancellous bone acts as a framework or "trellis" for vascular ingrowth 
from the host tissue. Osteoblasts populate the graft and deposit a layer of osteoid that 
surrounds a portion of the non-vital allograft. Urist (1976) termed this process 
incorporation. This new bone that is laid down with the cancellous graft leads to an 
initial increase in the density of the graft. The increased density leads to an initial 
increase in the mechanical strength of the cancellous graft. This could be a possible 
advantage of cancellous grafts in the early stages of graft healing. As the graft matures 
the necrotic bone is resorbed and the density of the grafted area returns to normal. This 
overall process of new bone surrounding non-vital graft that is eventually resorbed and 
replaced is termed creeping substitution. Over time creeping substitution leads to 
complete resorption of a cancellous graft. 
Cortical grafts are incorporated into a recipient site by a fundamentally different 
process than that of cancellous grafts. Urist (1967) termed the process of cortical graft 
incorporation "reverse creeping substitution". Cortical grafts are not nearly as porous as 
cancellous grafts initially. For vascular ingrowth or osteoconduction to occur some of the 
cortical graft is first resorbed by osteoclasts. This leads to a much slower vascularization 
process in cortical grafts as compared to cancellous grafts. Thus, the osteoconduction 
process of the cortical graft starts with an osteoclastic response. This is the opposite of 
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the cancellous grafts, which begin osteoconduction with an osteoblastic response. The 
result is that while cancellous grafts become denser during the early stages of healing, 
cortical grafts become less dense. This leads to an initial decrease in the mechanical 
strength of cortical bone grafts (Burchardt 1983). Finally, cortical bone grafts are not 
completely resorbed like cancellous grafts. Instead, they can remain a mixture of new 
vital bone and nonvital graft particles for many years. 
Table 2 
Graft Incorporation by Bone Type 
Cancellous Bone Graft Incorporation Creeping Substitution 
Cortical Bone Graft Incorporation Reverse Creeping Substitution 
While the structural aspects of a graft (cortical vs. cancellous) could playa role in 
the healing of a graft, other research has focused on the embryologic origin of the graft. 
Smith and Abramson (1974) studied auto grafts that were either membranous or 
endochondral in a rabbit model. Bone forms by two basic mechanisms in the body. 
Endochondral bone formation involves the calcification of cartilage, and 
intramembranous bone formation involves a direct transition from connective tissue to 
bone. The endochondral block grafts were obtained from the ilium and the membranous 
grafts from the skull. What they found was that the endochondral grafts lost a 
significantly larger portion of their initial volume than the membranous grafts. They 
postulated that this result was due to a difference in the normal stress levels placed on the 
different types of bone. The endochondral bone of the ilium was normally subjected to 
more stress then the membranous skull bone. When the endochondral bone was grafted 
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to a site where there was less stress it resorbed. They also hypothesized that since the 
endochonral bone had a larger cancellous content, it was easier for connective tissue 
vascularity to penetrate and resorb. 
Zins and Whitaker (1983) repeated the work of Smith and Abramson (1974) with 
the same results. They used both a rabbit and monkey model to conclude that 
membranous bone was superior for craniofacial grafting. They hypothesized that the 
reason for this was either a more rapid revascularization of the endochondral bone, or a 
delayed vascularization leading to slower resorption of the endochondral bone. Since 
endochondral bone has a larger cancellous component, it seems the latter is more likely 
based on the previously discussed work by Goldberg and Stevenson (1987). 
Ozaki and Buchman (1998) hypothesized that the success or failure of a block 
graft was not based on its embryologic origin, but on whether it was cancellous or 
cortical bone. They felt that the earlier results of Smith and Abrams were because the 
membranous grafts were primarily cortical bone and the endochondral grafts were a mix 
of cancellous and cortical bone. To test this hypothesis they used the same rabbit model 
to compare cortical and cancellous block grafts both of endochonral origin. They found 
significantly greater resorption of the cancellous grafts. In addition they compared 
cortical block grafts from endochonral bone to those taken from membranous bone and 
found no difference in the amounts resorbed. From this study they concluded that 
cortical block grafts were superior to cancellous block grafts. However, these studies 
were looking at autogenous onlay grafts meaning that no membrane was used. Therefore 
unlike guided bone regeneration where the cells of the surrounding connective tissue are 
blocked by a membrane, these connective tissue cells had direct access to the grafts. The 
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less permeable cortical bone would offer greater resistance to connective tissue 
penetration and resorption of the graft. 
There is very little in the literature about cancellous block allografts for ridge 
augmentation procedures. Leonetti and Koup (2003) published a report of four cases of 
ridge augmentations with a cortico-cancellous block allograft (Puros J-block). The 
blocks were shaped, secured in place with a titanium screw, and covered with a Biomend 
collagen membrane (Centerpulse). All of the sites were reentered at 6 months and 
implants were successfully placed and restored. Histology was obtained from one graft 
site that showed vital bone with no residual graft material. 
Keith (2004) also published a case report on the use of a cortico-cancellous block 
allograft (Puros J-block) used for ridge augmentation. He reentered the grafted site after 
four months of healing and found very little loss of the initially grafted dimensions. The 
initial ridge width of 3 mm was increased to 9 mm for a gain of 6 mm. A wide diameter 
implant was successfully placed in the site. 
The only report of an entirely cancellous block allograft for ridge augmentation 
was done by Lyford et al. (2003). He reported on five cases of ridge augmentations using 
the same cancellous block allograft material that was used in this study. The blocks were 
shaped, secured, and covered by either non-resorbable or resorbable membranes. He 
showed a mean initial ridge width of 3.4 mm that increased to 6.0 mm at 6 month reentry. 
Unfortunately, no histology was obtained in his study. 
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Membranes and Guided Bone Regeneration 
The idea of using a membrane to produce bone growth has it roots in orthopedic 
surgery. Hurley et al. (1959) described using a Millipore filter to guide bone growth in 
spinal fusion procedures. Membranes got their start in periodontics for use in guided 
tissue regeneration procedures (Gottlow et a1. 1984). Several years later membrane use 
would be applied to ridge augmentation procedures. The concept of using a membrane to 
promote bone growth in the mouth was developed by Dahlin et a1. (1988). The 
hypothesis was that the cells responsible for creating new bone in the body migrated to a 
wound site at a slower rate than the fibroblasts of the surrounding soft tissue. Therefore, 
if the site of desired bone growth was walled off, then only bone producing cells had 
access, and the wound site would fill entirely with new bone rather than soft tissue. 
Conversely, if the site were left exposed, the faster migrating gingival fibroblasts would 
repopulate the site first producing predominantly soft tissue. This idea had its roots in 
results from earlier studies that were using membranes to try to regenerate lost 
periodontium around diseased roots (Gottlow et a1. 1984). Gottlow et a1. (1984) stated 
that if bony defects around diseased roots were repopulated only by cells from the 
periodontal ligament and not the gingival connective tissue and epithelial cells, then a 
new attachment apparatus (new cementum, new bone, and new functionally oriented 
periodontal ligament) would form in the defect site. Dahlin et a1. (1988) used the same 
idea of a mechanical barrier or membrane to block unwanted cells. The difference was 
that the goal was not to regenerate a new periodontal apparatus. Instead, the goal was to 
create new bone only. Buser et a1. (1993) would later use the term guided bone 
regeneration to show that the membrane was being used to regenerate bone by itself, 
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while guided tissue regeneration referred to regenerating a new periodontal apparatus 
around a diseased root. 
Dahlin et al. (1988) began their work with guided bone regeneration by creating 
through and through bony defects in the mandibles of rats. The defects were produced 
bilaterally, with one defect covered on both sides by an expanded polytetrafluoroethlyene 
(ePTFE) membrane. The defect on the contralateral side was left open so that when the 
flaps were sutured the connective tissue of the flap had direct access to the defect. 
Complete bone fill only occurred in the groups where membranes were placed over the 
surgically created defects. Some bone was created in the control defects but was always 
intermixed with a large amount of fibrous tissue (Dahlin et al 1988). Dahlin et al. (1990) 
then conducted a similar study in monkeys in an effort to demonstrate the membrane 
effect in an animal model biologically closer to a human. Through and through defects 
were created in the mandibles and periapical defects were created in the maxilla. The 
results were very similar to their previous study in rats. Complete bone fill of the 
surgically created defect was obtained in the sites that were protected by a barrier 
membrane. 
Dahlin et al. (1988) used a non-resorbable ePTFE membrane that remains a 
popular membrane for guided bone regeneration procedures. The membrane is designed 
with pores large enough to allow the passage of fluid and nutrients, but small enough that 
the fibroblasts responsible for fibrous tissue formation are blocked. Since the membrane 
material is not resorbed by the body, it provides a barrier function for as long as it is in 
place at the defect site. The longevity of its barrier function is considered one of the great 
advantages of a non-resorbable membrane. The obvious drawback of a non-resorbable 
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membrane is the need for a second surgical procedure to remove the membrane. This is 
not a concern for guided bone regeneration procedures for implant site development, 
since a second surgery will already be necessary to place the implants. However, many 
GBR procedures are done at the time of implant placement or for esthetic purposes in 
fixed partial denture cases. To avoid a second surgical procedure, resorbable membranes 
were developed and tested (Sandberg et a1. 1993). Sandberg et al. (1993) repeated the 
experimental design that Dahlin et al. (1988) had used earlier, only this time the 
contralateral defects were used to compare a resorbable membrane 
(polylactic/polyglycolic acid copolymers) vs. a non-resorbable membrane (ePTFE). Both 
membranes led to comparable amounts of bone fill. 
A major disadvantage of non-resorbahle barriers is the increased incidence of 
wound dehiscence. Zitzmann et al. (1997) compared ridge augmentation procedures in 
twenty-five patients using a split mouth design where one defect was treated with a 
resorbable collagen membrane while the other received a non-resorbable membrane. The 
mean bone fill was 92% for the resorbable sites and 78% for the non-resorbable sites. 
The incidence of wound dehiscence and membrane exposure was 16% for the resorbable 
group and 24% for the non-resorbable group. At the six week exam that number had 
fallen to 9% in the resorbable group, but in the non-resorbable membranes group all of 
the dehiscences were still present. Zitzmann et al. (1997) then evaluated the effect of 
membrane exposure on the amount of bone filll. Simion et al. (1994) had previously 
reported decreased bone fill in GBR procedures with exposed ePTFE membranes. 
Zitzmann et al. (1997) found that there was 94% bone fill in the resorbable membrane 
group where the membrane did not become exposed vs. 87% when the membrane was 
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still exposed at six weeks. In the non-resorbable group the percent bone fill was 98% at 
the unexposed sites and 65% at the exposed sites. 
Table 3 
Barrier Membrane Exposure Summary 
Author/Year Total Cases Percent Exposed Cases Exposed 
Buser et al. 1990 12 2 17% 
Nevins and Mellonig 1992 3 2 66% 
Simion et al. 1992 1 5 20% 
Nevins and Mellonig 1994 4 4 100% 
Becker et al. 1994 3 2 66% 
Fugazzotto 1998 296 77 29% 
Chiapasco et al. 1999 15 2 13% 
Mattout and Mattout 2000 214 26 12% 
Assenza et al. 2001 22 4 18% 
Friedmann et al. 2002 14 10 71% 
Knapp et al. 2003 12 6 50% 
Chiapasco et al. 2004 11 3 27% 
Alloderm 
A material that has been used more recently as a barrier membrane is acellular 
dermal matrix or Alloderm. Alloderm is a soft tissue allograft material that is derived 
from cadaveric skin. The skin is harvested and then first treated to separate the epidermal 
cells from the dermal cells leaving the dermis layer and an intact basement membrane. 
From there the tissue is treated with a non-denaturing detergent that removes the cells of 
the tissue without disrupting the extracellular matrix that surrounds them. What remains 
is an acellular dermal matrix graft that facilitates revascularization and new tissue 
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formation at the recipient site. To preserve the tissue for later use the acellular dermal 
matrix is put through a patented freeze drying process that does not damage the 
extracellular matrix. 
Alloderm was originally developed as a skin allograft for burn patients. 
Previously used skin allografts were eventually rejected due to the foreign cells of the 
graft. In response to that problem this acellular dermal matrix was developed 
(Wainwright et al. 1996). Since that time Alloderm has been used for various other 
surgical procedures including, gingival augmentation and root coverage procedures in 
periodontal surgery (Henderson et al. 2001, Harris 1998), and as a repair mechanism for 
flap fenestrations with bone grafting procedures (Batista and Batista 2001). 
The acellular dermal matrix can be used as a barrier membrane for ridge 
augmentation (Johnston 2003). The downfall of some resorbable membranes is too rapid 
a resorption time. If the membrane is broken down and penetrated by gingival fibroblasts 
too quickly in the healing phase, it could compromise the amount of new bone that is 
regenerated. Eppley (2001) studied how quickly Alloderm revascularized when it was 
placed in a subcutaneous pouch in a rabbit ear. It was completely vascularized after two 
weeks healing and penetration of the blood vessels occurred equally fast on both the 
basement membrane and connective tissue sides of the Alloderm. Two things could 
potentially change the rate of revascularization in a ridge augmentation procedure for a 
human patient as compared to Eppley (2001). The first is the potential healing 
differences between a human and the rabbit. The second is that in a guided bone 
regeneration model the revascularization occurs from only the soft tissue side of the 
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Alloderm and has to penetrate the full thickness of the membrane to reach the grafted 
area. 
Wainwright et al. (1996) did histology on burn sites in humans that were grafted 
with Alloderm and then covered with a skin autograft. The histology at two weeks post 
surgery showed vascular penetration from the bed site to but not into the basement 
membrane (the Alloderm was placed with the connective tissue side facing the recipient 
site). In addition fibroblasts had also penetrated the Alloderm to, but not into, the 
basement membrane complex. This study has an advantage over Eppley (2001) in that it 
is human histology and not animal histology, but it is still difficult to say how applicable 
it is to a guided bone regeneration procedure in the mouth. Thus there is not much in the 
literature upon which one can base a statement of how long Alloderm would prevent 
gingival fibroblast penetration into a guided bone regeneration site. In fact there are only 
two randomized controlled studies that used Alloderm as a barrier membrane (Johnston 
2003, Cordini 2004) 
Johnston (2003) compared the barrier membrane effect of Alloderm to ePTFE in 
the treatment of class II furcation defects. No differences between the two membranes 
were reported, which showed Alloderm was successful as a barrier membrane in those 
procedures. Cordini (2004) used Alloderm GBR as a membrane for guided bone 
regeneration. Alloderm GBR is a thinner version of the standard Alloderm product 
specialized designed for guided bone regeneration procedures. Cordini (2004) found 
significant gains in horizontal ridge width using an Alloderm GBR membrane. 
There are several case studies that report the use of Alloderm as a barrier 
membrane. Novaes and Souza (2001) used Alloderm as a barrier membrane for a ridge 
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preservation procedure on site number lIon a 48 year old woman. Upon reentry 6 
months later new bone had formed allowing the placement of a 5.5 x 10 mm implant. 
Fowler et al. (2000) reported two successful cases of ridge preservation using Alloderm 
as a barrier membrane. Later that same year Fowler et al. (2000) published part two of 
that study where he presented a case report on an immediate implant placement and 
simultaneous guided bone regeneration around the implant using Alloderm as a 
membrane. The implant was placed and the GBR procedure was considered a success. 
Finally, Griffin et al. (2004) reported two ridge preservation cases using Alloderm as a 
membrane where implants were successfully placed 3 to 4 months later. He also reported 
a case where Alloderm was successfully used as a membrane in a guided bone 
regeneration procedure designed to cover a non-restorable implant. 
Based on randomized controlled trials and case reports there is support for the use 
of Alloderm as a barrier membrane in guided bone regeneration procedures. 
Guided Bone Regeneration Technique 
Dahlin et al. (1988) were the pioneers of guided bone regeneration, but it was 
Buser et al. (1990) and Nyman et al. (1990) that began the description of its technique in 
clinical practice. Buser et al. (1990) published technique articles for ridge augmentation 
in the maxilla (Buser et al. 1993) and the mandible (Buser et al. 1995). He outlined four 
prerequisites for predictable success with ridge augmentation procedures. 
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Table 4 
Buser et al. (1993) prerequisites for predictable GBR procedures 
I . Achievement of primary soft tissue closure and healing 
2. Use of an appropriate barrier membrane 
3. Stabilization and close adaptation of the membrane to the surrounding bone 
4. Creation and maintenance of a secluded space 
The first was the achievement of primary soft tissue closure and healing to avoid 
membrane exposure. The second was selection of the appropriate membrane. Buser et 
aI. (1993) felt this was a non-resorbable membrane in the case of GBR procedures 
because a reentry procedure for implants was always necessary. The third was 
stabilization and close adaptation of the membrane to the surrounding bone. This was 
necessary to prevent ingrowth of connective tissue cells into the defect. Finally Buser et 
aI. (1993) said that creation and maintenance of a secluded space was needed. He 
accomplished this by using tenting screws to hold out the membrane and by using filler 
materials hold out the membrane. Buser et al. (1993) first used collagen and then later 
switched to autogenous bone as the filler material. In addition to these prerequisites he 
later added surgical recommendations including; 1) perforation of the cortical bone plate 
to achieve a bleeding bone surface; 2) using an appropriate bone-filling material for 
blood clot stabilization; 3) fix and stabilize the membrane with fixation screws to prevent 
micromovement; and 4) the use of horizontal mattress and interrupted sutures to obtain 
tension free primary closure (Buser et al. 1995). 
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One of Buser et al. (1993) four prerequisites for a successful guided bone 
regeneration procedure is pnmary closure of the graft site. He describes making 
periosteal releasing incisions to obtain primary flap closure when suturing. He then later 
qualifies this prerequisite by saying that the primary closure should be obtained without 
tension at the flap margins. Seibert (1993) advocated tension free closure because he felt 
that tension on the flap would lead to collapse of the membrane thereby violating one of 
Buser's other prerequisites space maintenance. Another, possibly more important reason 
for tension free flap closure is to prevent failure of flap union and subsequent membrane 
exposure. In a review by Machtei (2001) the decreased effectiveness of guided bone 
regeneration if membrane exposure occurs was discussed. Bahat and Koplin (1989) 
described a "pantographic flap" that allowed coronal advancement and tension free 
closure of flaps during ridge augmentation procedures. More recently Greenwell et al. 
(2004) described a superficial split thickness flap for tension free closure. The advantage 
of the flap is extreme flap release that allows complete, passive flap coverage for 
virtually all ridge augmentation procedures. In addition, the flap creates an absence of 
muscle pull during healing, which prevents flap retraction and promotes wound closure. 
This is accomplished by sharp dissection of the flap to separate the epithelium and 
connective tissue layers from the underlying muscle and periosteum. This is in contrast 
to a traditional split thickness flap that separates the periosteum from the muscle layer. 
This leaves the muscle attachments to the flap and allows for pull on the flap during lip 
and cheek movements. 
As mentioned earlier one of the primary reasons for having tension free closure of 
the flap is to avoid membrane exposure. There are a multitude of studies and case reports 
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documenting incidence of membrane exposures with guided bone regeneration 
procedures. Table 1 lists many of these articles and the corresponding percentages. 
Machtei (2001) published a meta analysis on GBR studies that documented membrane 
exposures and the amount of bone formation that resulted. The two studies that met the 
inclusion criteria had a mean of 3.01 mm of new bone in the cases where no membrane 
exposure occurred vs. 0.56 mm in the cases where membrane exposure occurred. Simion 
et al. (1994) reported less bone formation around immediate implant sites with 
simultaneous GBR that became exposed. He found 41.6% graft take in the exposed 
membrane group vs. 96.6% in the non-exposed group. Clearly membrane exposure has a 
significant negative effect on the outcome of ridge augmentation. 
Buser et al. (1993) recommended making perforations in the cortical plate of the 
graft site with a small round bur. This created a bleeding bone surface that enhanced the 
outcome of the guided bone regeneration procedure. Two animal studies support this 
recommendation. The first was by Majzoub et al. (1997) where the bone was analyzed 
histologically. A titanium dome was attached to rabbit skulls and test sites had cortical 
perforations made in the areas covered by the domes while the control sites did not. Bone 
neogenesis was quicker and greater in quantity and density in the sites with cortical 
perforations. They hypothesized that the cortical perforations allowed for a quicker 
migration of bone forming cells from the medullary spaces to the site of bone formation. 
They also hypothesized that the injury to the cortical plate caused a release of bone 
morphogenic proteins. Carvalho et al. (2000) did a similar study in dogs with autogenous 
onlay grafts. He studied three different types of bed preparations. The first was an 
unperforated cortical plate, the second a perforated cortical plate, and the third a 
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decorticated plate. Histology showed poor incorporation of the grafts at the cortical plate 
sites, and good integration of the grafts on the perforated and decorticated sites. Thus 
both of these studies support Buser et al. (1993) recommendation that cortical 
perforations be made at the recipient graft site. 
One of Buser et al. (1993) prerequisites was the close adaptation and fixation of 
the membrane. The close adaptation of the membrane is needed to ensure exclusion of 
connective tissue cells. The fixation of the membrane leads into the idea of wound 
stability. A stable fibrin clot in the area of desired bone growth is crucial to new bone 
formation. Wikesjo and Nilveus (1990) and Haney et al. (1993) explored wound 
stabilization and its effects on healing guided tissue regeneration procedures. They used 
animal models to conclude that wound stabilization was an important part of the healing 
in GTR. Since GBR and GTR work on many of the same principles it seems reasonable 
to conclude that wound stabilization is important for ridge augmentation procedures as 
well. 
Buser et al. (1993) recommended a healing period of nine months for GBR 
procedures. Fugazzotto (1998), in a report on 302 consecutive ridge augmentation 
procedures, stated that the sites were reentered anywhere from four to ten months after 
grafting. In this study Gore-Tex membranes were used with various nonautogenous 
particulate grafts. He noted that the later the reentry the more mature the bone appeared. 
In another study by Fugazzotto and De Paoli (1999) they looked at the dimensional 
stability of ridge augmentation sites underneath pontic sites. Titanium reinforced Gore-
Tex membranes were used with either DFDBA+ trica1cium phosphate or Bio-Oss. Bone 
sounding was done as far out as thirty months post augmentation. They reported a 
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change of less than 0.1 mm in the buccopalatal dimension over the 30 month observation 
period. This supported longer periods of healing prior to reentry. However, in a clinical 
setting, patient demands for timely restoration may not allow for such long reentry times. 
As long as the reentry time is not so short that it compromises the success of the implants, 
shorter reentry times than the 9 months Buser et al. (1993) recommended seem 
reasonable. 
Another technical aspect of ridge augmentation procedures that Buser did not 
address was rigid fixation of block grafts. Lin et al. (1990) did a study on autogenous 
block grafts placed in one of two locations in a rabbit model. The grafts were placed 
either in an area where they would easily become mobile (femur), or in an area of 
relatively low mobility (snout). Blocks in each location were either rigidly fixated with a 
screw or loosely fixated with sutures. In the highly mobile femur recipient sites grafts 
that were rigidly fixated with a screw were much more successful. Since the oral cavity 
is a fairly mobile area of the body, with a multitude of muscle forces present at any given 
time, rigid fixation of block grafts with titanium screws seems advisable. 
Another aspect of ridge augmentation technique that Buser et al. (1993) did not 
address, but that has been discussed by Misch (1999), is the use of a combination of 
different graft materials in GBR procedures. Misch termed this the "sandwich" bone 
augmentation technique or the layered approach to bone grafting. Misch describes the 
technique as something to be used when there was insufficient autogenous bone available 
intraorally. The inner layer of the graft, closest to the recipient bone site, was always 
autogenous bone. The second or intermediate layer was a mixture of DFDBA and 
calcium phosphate resorbable alloplasts plus PRP. The intermediate layer was then 
20 
covered by either a resorbable or non-resorbable membrane depending on the time of 
desired barrier function. The calcium phosphate is needed for mineralization of new 
bone at the graft site, and the DFDBA and PRP provide bone morphogenic proteins that 
are needed for new bone formation. Wang et al. (2004) reported on five cases of ridge 
augmentation procedures where the graft used was three different layers of materials. 
The bottom layer was autogenous osseous coagulum, the middle layer was DFDBA 
particles, and the top was bovine derived HA. The technique was used around 
dehiscence defects on implants. They reported a mean of 10.5 mm of bone formation and 
100% defect fill. The rationale for this technique was that it allows the advantageous 
aspects of the different graft materials to be combined for a better overall result in GBR 
procedures. The osseous coagulum provides osteogenic properties not found in the other 
two grafts. The DFDBA is a readily available allogeneic material that can compensate 
for a lack of available autogenous bone, and the bovine HA is a slowly resorbing 
xenograft that will provide long term space maintenance properties. The idea of mixing 
different types of graft materials to exploit their individual advantages in GBR shows 
great promise based on the results of these case reports. 
Implant success in regenerated bone 
The ultimate goal for many guided bone regeneration procedures is successful 
implant placement. Several studies have examined the long term stability of implants 
placed in grafted bone. Fugazzotto (1997) evaluated success rates of 626 implants 
according to Albrektsson' s criteria. 
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Table 5 
Albrektsson's Criteria of Implant Success (Albrektsson et al. 1986) 
1. An individual, unattached implant is immobile when tested clinically. 
2. A radiograph does not demonstrate any evidence of peri-implant radioloucency. 
3. Vertical bone loss is less than 0.2 mm annually following the implant's first year of 
serVIce. 
4. Persistent or irreversible signs or symptoms, such as infection, pain, paresthesia, 
neuropathies, or violation of the mandibular canal, are absent. 
5. Of the implants tested for the above mentioned criteria, 85% are proven successful 
after 5 years and 80% after 10 years in function. 
Table 6 
Albrektsson's Revised Criteria of Implant Success (Roos et al. 1997) 
1. An individual, unattached implant is immobile when tested clinically 
2. All implants must be individually radiographed and show no evidence of loss of 
integration 
3. Bone loss is less than 1.0 mm in the first year, followed by less than 0.2 mm 
annually thereafter. 
4. Severe adverse events, ie, complications resulting in changes of the treatment plan 
(Helsinki Declaration), are absent. 
5. The percentage of implants falls within the stated range in the following categories: 
unaccounted for < 25%; failures: < 10%; success: > 80% of the surviving implants 
after 5 years in function. 
All implants were placed in regenerated bone either at the time of grafting or months later 
using a staged approach. The observation period for the implants was up to 51 months 
after initial loading. There was a cumulative success rate of 93.8% overall, 94.9% in the 
maxilla, and 91.9% in the mandible. Nevins et al. (1998) also studied long term success 
rates of implants placed in regenerated bone. They reported on 526 implants placed in 
either at the time of grafting or later using a staged approach. Some of the grafts were 
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done using autogenous bone, and some were done with allogeneic bone. The follow-up 
time ranged from 6 to 74 months post-loading. The overall success rate was 97.5%. In 
addition there was no difference in the success rates of the implants placed in autogenous 
grafted bone compared to those placed in allograft bone. Fritz et al. (2001) evaluated the 
success of implants in regenerated bone from a histologic perspective. Implants were 
placed in monkeys in both native and regenerated bone and then loaded with a fixed 
prosthesis for one year. The same radiographic and histologic appearance was seen in 
both native bone and regenerated bone sites. Also, bone to implant contact showed no 
significant difference between the implants in native bone (59%) and the implants in 
regenerated bone (65%). Based on the results of these studies it is clear that implants 
placed in regenerated bone are just as successful as those placed in native bone. 
Dimensional Gains 
While the successful placement of an implant is the ultimate goal of many ridge 
augmentation procedures, the success is determined by the amount of new bone that can 
be generated by the procedure. Buser (1990) studied humans with an ePTFE membrane 
alone for ridge augmentations. The data from seven patients was reported as starting 
with a mean initial width of 3.6 mm that increased to a mean of 6.1 mm for a mean gain 
of 2.5 mm in ridge width. However, the range of gains in ridge width was from 0 to 5.5 
mm showing a large variation in the results. 
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Table 7 
Barrier Membrane Alone Horizontal Augmentation 
Author # Initial Final Change Range Histology Cases (mm) (mm) (mm) (mm) 
Buser et al. 7 3.6 6.1 2.5 0- 5.5 Yes 1990 
Buser et al. (1993) later recommended the addition of a bone graft or filler under 
the membrane to prevent the collapse seen in his earlier study. Feuille et al. (2003) 
reported on ridge augmentations in ten patients using titanium reinforced membranes and 
FDBA. At six month reentry 69% of the grafted horizontal dimension had been lost and 
nearly all of the grafted vertical dimension was lost. The mean initial width was 4.25 
mm. The mean width at reentry was 7.4 mm for a gain of 3.2 mm. The vertical gain was 
0.4 mm. The histology in this study showed a range of 43 to 70% new bone formation 
for a mean of 48%. Residual graft particles represented from 30 to 57% of the biopsy 
cores for a mean of 52%. 
Kaufman et al. (2003) reported two cases of ridge augmentations with titanium 
reinforced ePTFE membranes and a mixture of autogenous bone cores and DFDBA. At 
five month reentry one site gained 4 mm in ridge height and the other site gained 5 mm of 
ridge height. That corresponded to a mean vertical gain of 4.5 mm. 
Lyford et al. (2003) reported on three ridge augmentation procedures using either 
a BioMend Extend or ePTFE membrane combined with a cancellous block allograft. The 
mean initial ridge width was 3.4 mm. At reentry 6 months later it was a mean of 6.0 mm 
for a gain of 2.6 mm. The range was 2.0 mm to 4.0 mm. 
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Finally Keith (2004) published a case report on ridge augmentation with a 
Biomend membrane and a cortico cancellous (Puros l-block) block allograft. The initial 
ridge width was 3 mm and increased to 9 mm at 4 month reentry. This corresponds to a 6 
mm gain in ridge width. 
Table 8 
Barrier Membrane with Allograft Horizontal Augmentation 
Author # Initial Final Change Range Histology Cases (mm) (mm) (mm) (mm) 
Feuille et al. 
10 4.3 7.4 3.2 1.5 - 5.0 Yes 2003 
Lyford et al. 3 3.4 6.0 2.6 2.0-4.0 No 2003 
Keith 1 3.0 9.0 6.0 NA No 2004 
Mean 14 3.9 
Table 9 
Barrier Membrane with Allograft Vertical Augmentation 
Author # Initial Final Change Range Histology Cases (mm) (mm) (mm) (mm) 
Feuille et al. 
10 8.2 7.8 0.4 -4.0- 2.0 Yes 2003 
Kaufman et 1 NA NA 4.5 4.0- 5.0 No 
al. 2003 
Mean 11 2.5 
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Graft Comparisons 
One animal study compared several different types of grafts placed under titanium 
reinforced membranes (Buser et al. 1998). Bony defects were created in pig mandibles 
and then grafted them with either autogenous bone chips, tricalcium phosphate, 
hydroxylapatite, collagen sponge, or DFDBA 250-500 micrometers. The grafts were 
allowed to heal for a period of 6 months and then evaluated histologically. The results 
are presented in table 5. All of the grafting materials produced significant amounts of 
new bone. HA had the largest percentage of filler material still present. 
Table 10 
Histomorphometric Summary Analysis I 
Filler % Vital Bone % Marrow %Nonvital S~ace Bone 
Blood clot 55.3 44.8 0 
Collagen 50.7 49.3 0 
Autograft 53.6 35.3 11.0 
DFDBA 43.6 43.1 13.3 
TCP 69.7 24.6 5.8 
HA 49.0 20.5 30.6 
Jovanovic and Nevins (1995) reported three GBR cases in humans. A titanium 
membrane alone was compared to a membrane plus an autograft, and to a membrane plus 
an allograft. The membrane alone site was 2 mm in width initially. At 12 month reentry 
the width was 7 mm for an increase of 5 mm. In the membrane plus autograft the initial 
ridge width was again 2 mm. At the two month reentry the ridge width was 8 mm for a 
gain of 6 mm. Finally, in the membrane plus allograft group the initial ridge width was 3 
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mm and it increased to 9 mm at 7 month reentry for a gain of 6 mm of ridge width. 
Based on this study and the previous one by Buser et al. (1998) there does not seem to be 
much difference in the quantity and quality of bone regenerated as long as sound guided 
bone regeneration technique is used. This can be seen in the following table that 
summarizes width increases in GBR studies. 
Table 11 
Jovanovic and Nevins (1995) 
Initial Ridge Final Ridge Ridge Width Reentry Time 
width Width Gain 
Membrane 2mm 7mm 5mm 12 months Alone 
Membrane and 2mm 8mm 6mm 2 months Autograft 
Membrane and 3mm 9mm 6mm 7 months Allograft 
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Table 12 
GBR Horizontal Augmentation Summary 
Treatment Type # Studies # Cases Width Increase (mm) 
Barrier Membrane Alone 1 7 2.5 
Barrier Membrane with Allograft 3 14 3.9 
Barrier Membrane with Alloplast 3 37 2.0 
Barrier Membrane with Autograft 3 43 3.9 
Barrier Membrane with Various Grafts 2 14 3.2 
Comparative Allograft and Autograft 1 3 5.7 Studies 
Comparative Autograft Studies 2 20 3.2 




Study Design. Twenty-four patients were invited to participate in this 
randomized, controlled, blinded clinical trial for ridge augmentation by guided bone 
regeneration treatment with an acellular dermal matrix allograft (Alloderm, Biohorizons, 
Inc., Birmingham, AL.) as a barrier membrane. Patients were randomly placed into 
either the positive control or test group based on the result of a coin toss. The positive 
control group was treated with a cancellous block allograft, and the test group was treated 
with freeze dried bone allograft particles (500-1000 microns in diameter). 
After four months of healing all sites were reentered and an implant was placed. 





1. The patient must have at least a one tooth area with a ridge defect, treatment 
planned to receive a dental implant. The site must be bordered by at least one 
tooth. 
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2. The patients must be at least 18 years old. 
3. Patients must sign an informed consent to clinical research previously 
approved by the University of Louisville Human Studies Committee. 
Exclusion Criteria 
1. Patients with uncontrolled diabetes, immune diseases or other contraindicated 
systemic diseases. 
2. Patients with uncontrolled periodontal disease, and unwillingness to undergo 
needed periodontal treatment or patients with any other diseases that affect the 
periodontium. 
3. Patients with an allergy to any material or medication used in the study. 
4. Patients who need prophylactic antibiotics. 
5. Previous head and neck radiation therapy. 
6. Chemotherapy in the previous 12 months. 
7. Severe psychological problems. 
Post-Surgical Exclusion 
1. Patients that fail to follow the post-operative protocol will be reported but will 
not be included in the data analysis. 




Each patient received a diagnostic work-up including standardized radiographs 
(periapicals), study models, clinical photographs, and a clinical examination of teeth 
adjacent to the augmented sites. An acrylic stent was fabricated from which 
intraoperative vertical and horizontal hard tissue measurements were taken. 
Baseline data was collected just before the surgical phase of the treatment. 
Baseline data included: 
1. Plaque Index: Silness and Loe 1964. (Appendix A). 
2. Gingival Index: Loe et al. 1967 . (Appendix B). 
3. Bleeding on Probing: Dichotomous. 
4. Clinical Tooth Mobility: measurement by using the modified Miller's Index. 
(Appendix C). 
5. Gingival Margin Levels: measurement from CEl to the gingival margin. 
6. Keratinized Gingiva Width: measured from the gingival margin to the 
mucogingival junction. 
7. Clinical Attachment Level: measurement from CEl to the bottom of the 
clinical periodontal pocket. 
8. Radiographic Examination: Periapical radiograph on personalized Rinn XCP. 
(Appendix D). 
9. Soft Tissue Thickness: SDM gingival thickness meter. (Appendix H). 
10. Clinical photographs. 
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Soft tissue thickness and hard tissue measurements were done by two blinded 
examiners. Any measurements that differed by more than 1.0 mm were repeated until the 
difference between the two examiners was less than 1.0 mm. 
Surgical treatment. Patients were anesthetized with 2% lidocaine with 
epinephrine 1: 100,000. Horizontal crestal incisions were made midcrestally on the 
mandibular sites with care taken to preserve keratinized tissue on both sides of the 
incision. In maxillary sites the horizontal incision was made 10-15 mm palatal to the 
palatal line angles of the adjacent teeth. Long vertical incisions were made on the buccal 
from the mesial and distal extents of the horizontal incision. The vertical incisions were 
designed to diverge as much as possible. A superficial split thickness flap (Greenwell et 
al. 2004) was reflected on the buccal, and a full thickness flap was reflected on the 
lingual. Periosteum and muscle layers were reflected on the buccal to expose the ridge 
defect. 
Ridge width was measured at the crest and 5 mm apical to the crest by both 
examiners using a digital caliper. Vertical hard tissue measurements were taken using the 
custom made acrylic stent (Appendix F). 
The coin toss was performed at this time to determine the patient's treatment 
assignment. The positive control group had a cancellous block allograft (Allosource, 
Inc., Centennial, CO.) shaped using carbide burs under copious irrigation. The block was 
shaped to closely adapt to the alveolar ridge without any sharp edges. Numerous cortical 
perforations were made at the recipient site with a 112 or 2 round bur. The block graft 
was secured to the recipient with either one or two titanium screws (Salvin Dental 
Specialties, Inc., Charlotte, NC). Any voids left by the block graft were filled with freeze 
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dried bone allograft particles (500-1000 microns), and the block graft was overlayed by 
particulate graft as well. The graft was covered by an Alloderm barrier membrane that 
extended at least 3 mm beyond the graft border in all directions. 
The test sites were prepared with cortical perforations in the same manner as the 
positive control sites. Two or more titanium screws were placed in the recipient site. 
The screws were left protruding from the alveolar ridge so that they defined the desired 
post-graft ridge dimensions. The Alloderm barrier membrane was secured apically on 
the buccal with two or three titanium tacks. Freeze dried bone allograft particles (500-
1000 microns) were packed into the recipient site to the dimensions set by the screws. 
The Alloderm membrane was then pulled over the graft and tucked on the lingual or 
palatal aspect. Post graft ridge width and vertical stent measurements were then 
performed by both examiners. 
Primary closure was then obtained in all cases using a resorbable monofilament 
(Maxon 5.0) suture. One to three deep horizontal mattress sutures were placed 10 mm 
apical to the horizontal wound margins to remove tension from the wound margins. The 
horizontal and vertical wound margins were then closed with numerous interrupted and 
horizontal mattress sutures. All procedures were documented with clinical photographs. 
Patients were given doxycycline 50 mg, 1 tab qd, for 2 weeks; naproxen 375 mg, I tab 
bid, for I week, Vicodin ES, 1 tab q 4-6 h, as needed for pain, and chlorehexidine 0.12%, 
bid rinse, for 3 weeks. All patients were seen on a weekly basis until soft tissue closure 
was obtained. Post-op visits included supragingival plaque removal and oral hygiene 
reinforcement. Sutures were removed at the 3 week post-op appointment. 
34 
All sites were reentered at least 4 months after the ridge augmentation surgery. 
Clinical measurements were repeated as performed prior to the initial surgery. Patients 
were anesthetized with 2% lidocaine with epinephrine 1: 100,000. A superficial split 
thickness flap was reflected on the buccal so primary closure could be assured if 
additional grafting were needed. A 2.7 X 6 mm biopsy core was taken from the implant 
site. Ridge width and vertical measurements were repeated by both examiners. Implants 
were placed and any dehiscence sites were grafted with freeze dried bone allograft 
particles (500-1000 microns). Flaps were replaced and sutured with 4.0 chromic gut 
sutures. Patients were given the same post operative medications as those prescribed 
after the initial surgery. 
Histologic Analysis. Trephine core specimens (2.7 X 6 mm) were decalcified, 
sectioned, and prepared for histologic analysis using hematoxylin and eosin staining. 12 
to 15 step serial sections were taken from the center of each longitudinally sectioned 
trephine core. Six randomly selected fields, 1 per slide if possible, were used to obtain 
percent cellular bone, acellular bone, and trabecular space using an American Optics light 
microscope at 150X, with a lOX objective and Nikon 15X reticle eyepiece, Appendix H. 
Statistical Analysis. A 2-way ANOV A was used to evaluate the statistical 





Alveolar Ridge Width Changes at Crest. The block or positive control group 
had an initial ridge width of 3.3 ± 0.9 mm at the crest. At reentry the ridge width was 7.1 
± 1.0 mm for an increase of 3.8 ± 1.3 mm (Table 13). This increase was statistically 
significant (p < 0.05). The particulate or test group had an initial ridge width at the crest 
of 4.4 ± 1.0. At reentry the width was 7.7 ± 1.5 mm for an increase of 3.3 ± l.1 mm. 
That increase was statistically significant (p < 0.05). There was no statistically significant 
difference between groups (p > 0.05) 
Predictability of Ridge Width at Reentry. For a standard diameter implant to be 
placed completely in bone it is necessary to have a ridge width of 6 mm or greater. In the 
block and particulate groups that was the case group 83% of the time. (Table 13). For a 
wide diameter implant to be placed entirely in bone a ridge width of 7 mm or greater is 
necessary. This was the case in 50% of the block cases and 75% of the particulate cases 
(Table 13). A ridge width of less than 4 mm might preclude implant placement entirely. 
None of the reentry ridge widths in either the block or particulate groups were 4 mm or 
less (Table 13). 
Alveolar Ridge Width 5 mm Apical to the Crest. The block group had an 
initial ridge width of 5.6 ± l.1 mm at 5 mm apical to the crest. At reentry the ridge width 
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was 9.0 ± 1.2 mm for an increase of 3.4 ± 1.0 mm (Table 14). The particulate group had 
an initial ridge width of 6.9 ± 1.1 mm 5 mm apical to the crest. At reentry the ridge 
width was 9.7 ± 1.7 mm for an increase of 2.9 ± 1.0 mm. Both groups had statistically 
significant increases within the groups (p < 0.05). There was no difference between the 
groups (p > 0.05). 
Loss of Augmented Ridge Width at the Crest. The initial augmented ridge 
width for the block group was 8.7 ± 1.0 (Table 15). At reentry the ridge width was 7.1 ± 
1.0 mm for a loss of 1.6 ± 1.0 mm of augmented ridge width (18 ± 11 %). The initial 
augmented ridge width for the particulate group was 9.0 ± 0.9 mm. At reentry the ridge 
width was 7.7 ± 1.5 mm for a loss of 1.4 ± 1.4 mm (15 ± 15%) of augmented width. 
Both of the groups had statistically significant changes within the groups, but there was 
no significant difference between the groups (p > 0.05) . 
Alveolar Ridge Height Changes. Ridge height changes for the mid sites in the 
block group was a gain of 0.7 ± 1.0 mm (Table 16). This was a statistically significant 
increase (p < 0.05). Ridge height change for the mid sites in the particulate group was a 
gain of 0.3 ± 0.6 mm. This was not a statistically significant change (p > 0.05). The 
mean mesial ridge height change for the block group was 0.3 ± 0.8 mm and for the 
particulate group was 0.1 ± 0.7 mm. The mean distal ridge height change for the block 
group was 0.2 ± 1.1 and for the particulate group was 0.4 ± 1.1 mm. None of the mesial 
or distal changes were statistically significant ( p > 0.05). There was no statistically 
significant difference between the groups (p > 0.05) (Table 16). 
Histologic Evaluation. The percentage of vital bone at the implant site in the 
block group was 51 ± 18% (Table l7). The percentage of vital bone at the implant site 
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for the particulate group was 58 ± 12%. The percentage of non-vital bone in the block 
group was 11 ± 9%. The percentage of non-vital bone in the particulate group was 11 ± 
7%. 
Predictability of Planned Implant Placement. In the block group implants 
were placed as planned in 12 of 12 sites or 100% of the time (Table 18). In the 
particulate group implants were placed as planned or a larger diameter in 12 of 12 sites or 
100% of the time. 
Soft Tissue Thickness Changes. In the block group the occlusal sites had a 
mean increase of 0.8 ± 0.7 mm of soft tissue thickness (Table 19). The increase was 
statistically significant (p < 0.05). The buccal sites had a mean increase of 0.3 ± 0.7 mm, 
and the lingual sites had a mean increase of 0.4 ± 0.6 mm. Neither the buccal nor lingual 
changes were statistically significant. In the particulate group the mean increase of soft 
tissue thickness was 0.6 ± 1.0 mm on the buccal and 0.3 ± 0.7 mm on the occlusal. 
Neither of these changes was statistically significant. The soft tissue thickness increased 
0.3 ± 0.4 mm on the lingual sites. This was a statistically significant increase (p < 0.05). 
There was no statistically significant difference between the groups (p > 0.05). 
Clinical Indices. The plaque index, gingival index, and bleeding on probing 
values for the test and positive control groups were initially very low with minimal 
differences between groups (Table 20). There was no statistically significant difference 
between groups (p > 0.05). At reentry the values had increased slightly with no clinical 
or statistical significance between groups from intial to final (p > 0.05). 
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Table 13 
Ridge Width Changes at the Crest for Block and Particulate Allograft Sites 
Treatment Initial Final Change 
Mean ± sd 
Block 3.3 ± 0.9 7.1 ± \.0 3.8 ± 1.3* 
Particulate 4.4 ± \.0 7.7 ± \.5 3.3 ± \,1 * 
Range 
Block 2.0 - 4.5 5.6 - 9.0 1.8 - 5.8 
Particulate 3.0 - 5.9 5.2 - 10.6 1.6 - 4.7 
Frequency 
~6mm ~7mm :54 mm 
Block (number) 10/12 6112 0/12 
Block (percent) 83 50 0 
Particulate (number) 10/12 9112 0112 
Particulate (percent) 83 75 0 
.. 
* = p < 0.05 between InItIal and 4-month values 
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Table 14 
Ridge Width Changes 5 mm apical to the Crest for Block and Particulate Allograft Sites 
Treatment Initial Final Change 
Mean ± sd 
Block 5.6±1.1 9.0 ± 1.2 3.4 ± 1.0* 
Particulate 6.9 ± 1.1 9.7 ± 1.7 2.9 ± 1.0* 
Range 
Block 4.4-7.7 7.4-11.0 1.7 - 5.2 
Particulate 5.1-8.4 6.9 - 12.5 1.3 - 4.5 
.. 
* = p < 0.05 between InItIal and 4-month values 
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Table 15 
Loss of Augmented Ridge Width at the Crest for Block and Particulate Allograft Sites 
Treatment Augmented Width Re-entry Change 
Mean ± sd 
Block 8.7 ± 1.0 7.1 ± 1.0 -1.6 ± 1.0* 
Block percent loss 18 ± II 
Particulate 9.0 ± 0.9 7.7 ± 1.5 -1.4±I.4* 
Particulate % loss 15 ± 15 
... 
* = p < 0.05 between InItial and 4-month values 
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Table 16 
Ridge Height Changes Relative to a Stent for Block and Particulate Sites 
Location Block Particulate Block Particulate 
Mean ± sd Range 
Mesial 0.3 ± 0.8 0.1 ± 0.7 -0.5 - 1.8 -0.8 - 1.5 
Mid 0.7 ± 1.0* 0.3 ±0.6 -0.5 - 2.2 -0.5 - 1.5 
Distal 0.2 ± 1.1 0.4 ± 1.1 -1.0 - 2.5 -0.8 - 3.3 
.. 
* = p < 0.05 between InItial and 4-month values 
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Table 17 
Histologic Data for Block and Particulate groups 
Mean ± sd 
% % % % 
Group Time n 
Vital Non-vital Trabecular Amorphous 
Treatment Groups 
Block 4 rno 11 51 ± 18 11 ± 9 31 ± 17* 7 ± 6* 
Particulate 4 rno 10 58 ± 12 11 ± 7 17 ± 8 14 ±6 
Age 
~ 50 4 rno 12 52 ± 16 12 ± 6 25 ± 16 11 ± 7 
<50 4 rno 9 56 ± 16 10 ± 9 25 ± 15 9±6 
Bone Quality 
Type II 4 rno 14 57 ± 16 12 ± 9 19 ± 11 12 ±6 
Type III 4 rno 7 48 ± 15 9±5 37 ± 16 7±6 
Tooth Type 
Anteriors 4 rno 3 52 ± 6 5±4 38 ± 3 5±4 
Premolars 4 rno 8 50 ± 18 13 ± 8 26 ± 18 11 ± 7 
Molars 4 rno 10 58 ± 17 11 ± 8 19 ± 13 12 ±7 
* = p < 0.05 between block and particulate groups 
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Table 18 
Predictability of Planned Implant Placement Entirely within Hard Tissue 
Sites Planned Placed Planned Placed Smaller Size Size Size 
Block 
Reduced 7,10 2 2 0 
Regular 6,20,20,20,21,28,29 7 7 0 
Wide 19,19,19 3 3 0 
Planned Placed as planned in 12 of 12 sites or 100% of the time Placement 
Total Placement 100% 
Particulate 
Reduced 0 0 0 
Regular 4,5,20,29 5 4 0 
Wide 19,19,19,19,29,30,30,30 7 8 0 
Planned Placed as planned or larger size in 12 of 12 sites or 100% of the time Placement 
Total Placement 100% 
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Table 19 
Soft Tissue Thickness Changes for Block and Particulate Sites 
Mean ± sd in mm 
Initial Final Change 
Block 
Buccal 1.4 ± 0.6 1.7 ± 0.6 0.3 ± 0.7 
Occlusal 1.8 ± 1.1 2.6 ±0.9 0.8 ± 0.7* 
Lingual 1.4± 1.3 1.8 ± 1.3 0.4 ± 0.6 
Particulate 
Buccal 1.3 ± 0.6 1.9 ± 0.8 0.6 ± 1.0 
Occlusal 1.8 ± 0.4 2.1 ±0.9 0.3 ±0.7 
Lingual 1.0 ± 0.9 1.3 ± 0.7 0.3 ± 0.4* 
.. 
* = p < 0.05 between initial and 4-month values 
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Table 20 
Clinical Indices for Block and Particulate Sites 
Mean ± sd in index units 
Initial Final Change 
Plaque Block 0.3 ± 0.4 0.4 ± 0.3 0.1 ± 0.4 
Index Particulate 0.4 ± 0.5 0.6 ± 0.7 0.3 ± 0.6 
Gingival Block 0.4 ± 0.3 0.7 ± 0.5 0.3 ± 0.4 
Index Particulate 0.4 ± 0.4 0.5 ± 0.4 0.2 ± 0.5 
Bleeding Block 0.3 ± 0.3 0.4 ± 0.3 0.1 ± 0.3 
on 
Probing Particulate 0.3 ± 0.3 0.5 ± 0.3 0.1 ± 0.3 
.. 




In this 4 month randomized, controlled blinded clinical trial a cancellous block 
allograft (Block) was compared to a mineralized particulate allograft (Particulate) 
utilizing acellular dermal matrix (ADM) as a barrier membrane. No clinically or 
statistically significant differences were found between groups In ridge dimension 
(Tables 13 and 14) change or histologic outcome data (Table 17). 
The primary outcome variable was crestal ridge width. The mean final crestal 
width was 7.1 ± 1.0 mm for the Block group and 7.7 ± 1.5 for the Particulate group 
(Table 13). This represented a gain of 3.8 ± 1.3 mm for the Block group and 3.3 ± 1.1 
mm for the Particulate group (Table 13). Analysis of frequency data showed that both 
the Block and Particulate groups achieved a crestal width of 2:: 6 mm 83% of the time 
while a crestal width of 2:: 7 mm was obtained 50% of the time in the Block group and 
75% of the time in the Particulate group (Table 13). Crestal width of $ 4 mm did not 
occur with either treatment (Table 13). A crestal width of 4 mm was considered 
inadequate to allow implant placement totally within bone. Final ridge width is 
dependent, to some extent, on the initial treatment goal which can vary depending on the 
size of the implant planned for the site. Thus a 4 mm standard diameter implant would 
require a minimum crestal ridge width of 6 mm, a 5 mm wide diameter implant would 
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require a 7 mm width, while a 3.25 mm reduced diameter implant would require a 5 mm 
crestal width. 
Predictability of plannned implant placement totally within bone was 100% for 
both the Block and the Particulate group. There were 2 reduced, 7 standard and 3 wide 
implants planned for the Block group and 5 regular and 7 wide for the Particulate group 
(Table 18). This analysis may best indicate how well each treatment accomplished the 
goal. 
Crestal ridge width is not the only important outcome when adequate ridge 
dimension to allow implant placement totally within bone is the goal of the ridge 
augmentation procedure. In many cases the ridge may be severely undercut or concave 
on the facial, or may simply have a narrow dimension apically. Ridge width changes 5 
mm apical to the crest were taken as a measure of how well the apical portion of the graft 
site responded. In general the graft extended 10 to 12 mm apical to the actual or desired 
crest. The Block group gained 3.4 ± 1.0 mm in this area of the graft site while the 
Particulate group gained 2.9 ± 1.0 mm. Both of these gains were statistically significant 
(Table 14). The Particulate group gained about 0.5 mm less at the crest and at 5 mm 
apical to the crest than the Block group, however, the final ridge width was slightly 
greater for the Particulate group and more wide diameter implants were planned for this 
group (Tables 13 and 18). 
The loss of augmented ridge width was similar for both groups, 18% for the 
Block group and 15% for the Particulate group (Table 15). Previous studies have shown 
similar losses of 16 and 17% for a cancellous block allograft (Cordini 2004, Lyford et al. 
2003). Some loss of augmented width is expected and the change observed in this study 
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was considered minimal. Expected loss associated with a particular graft material is 
useful to know when the graft is placed so that the augmented dimension can be 
increased to offset the expected loss. This data may not be generalizable to other block 
or particulate grafts that could have a different healing pattern. 
Ridge height gain measured from a stent was minimal in this study (Table 16). 
This reflects the type of ridge defect entered into the study. Any patient that met the 
inclusion criteria was consecutively entered into the study and randomly assigned to a 
treatment group. Most of the defects encountered were ridge width deficiencies with 
minimal loss of height. Thus this study did not test how well these materials would 
respond in vertical defects. 
Histologic analysis of data obtained from 2.7 X 6 mm trephine cores harvested at 
the implant placement site showed no significant differences between groups (Table 17). 
Considering the fact that allografts were used there was high percentage of vital bone and 
a minimal percentage of nonvital residual graft found at the implant sites. This may be 
partially due to the fact that the trephine core was taken at the site of implant placement 
rather than totally within grafted bone. Histology at the implant site was considered most 
important, however, the composition of the core may not refect graft histology alone but 
a combination of native and grafted bone. At 3 sites the core broke apart during removal 
from the trephine and was not available for analysis. 
Since there were minimal differences in the histology between groups subsequent 
analyses were performed without regard to the treatment group. When patients ~ 50 
years of age were compared to those < 50 minimal differences were found (Table 17). 
The mean age of those ~ 50 was 64 ± 7 while the mean age of the group < 50 was 40 ± 8. 
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Site stratification by tooth type also showed minimal histologic differences between 
anterior, premolar and molar sites although there was slightly more vital bone and less 
trabecular space in the molar sites (Table 17). In this study 17 of 21 cores were from 
mandible sites while only 4 were from the maxilla, therefore, this data primarily reflects 
the histologic outcome in mandibular sites. 
Bone quality was subjectively assessed using the criteria of Lekholm & Zarb 
(1985). Fourteen sites were considered Type II bone while 7 were assessed as Type III. 
Histologic analysis of these sites showed 57% vital bone and 19% trabecular space at 
Type II sites while Type III sites had 48% vital bone and 37% trabecular space (Table 
17). Thus while the bone quaality assessment is subjective the histologic compostion of 
the sites supports the groupings made in this study. 
The acellular dermal matrix used as a barrier membrane also served as a soft 
tissue graft and increased the soft tissue thickness of the buccal and lingual flaps. Total 
ridge width, independent of hard tissue changes, was increased by about 0.8 mm for both 
groups due to the increase in soft tissue thickness (Table 19). This indicates that ADM 
may offer an advantage independent of its membrane effect. Previous studies have 
shown that a loss of soft tissue thickness is associated with the use of resorbable 
membranes. This can be problematic at certain implant sites since thin tissue can allow 
the metal implant collar to show through giving the soft tissue and unesthetic, bluish hue. 
Ridge width changes in this study were comparable with previous FDBA or 
cancellous block allograft case series (Feuille et al. 2003; Lyford et al. 2003). This study 
found about a mean 3.5 mm gain for both groups while previous reports showed about a 
2.9 mm mean gain (Table 8). The mean height gain in this study was about 0.3 mm 
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while previous cases series have reported about 0.4 (Feuille et al. 2003)(Table 9). It 
should be pointed out that all comparisons are to case series where cases can be selected 
for treatment. This study was a randomized, controlled, blinded clinical trial that 
consecutively entered all cases that met the inclusion criteria. 
Comparison of data from this study with a previous block autograft case series 
shows similar results. The mean ridge data from a 40 case series shows a 3.6 mm width 
gain. The minimal differences between these studies indicates that the source of the graft 
material, autogenous or allogeneic, may have minimal influence on the treatment 
outcome. Wallace and Froum (2003) reported that for sinus grafts there was little 
difference in implant survival rates when particulate autogenous, allogeneic, xenogeneic 
and alloplastic materials were compared. Use of graft materials that do not require a 
second surgical site and avoid donor site morbidity represents a significant advantage for 
the patient and may increase case acceptance when ridge augmentation is required. 
Additional randomized, controlled blinded clinical trials are needed to confirm this 
observation. 
In summary, comparison of cancellous block and mineralized particulate allograft 
showed similar ridge width and height gains. The acellular dermal matrix membrane also 
served as a soft tissue graft and increased total ridge width by about 0.8 mm. The 
increased tissue thickness may provide an advantage in preventing unesthetic tissue color 




Mean crestal ridge width gain following ridge augmentation was not significantly 
different between a cancellous block allograft and a mineralized particulate allograft 
using acellular dermal matrix as a barrier membrane. (Table 13) 
Mean ridge height gam following ridge augmentation was not significantly 
different between a cancellous block allograft and a mineralized particulate allograft 
using acellular dermal matrix as a barrier membrane. (Table 16) 
The histologic compostion of the implant placement site following ridge 
augmentation was not significantly different between a cancellous block allograft and a 
mineralized particulate allograft using acellular dermal matrix as a barrier membrane 
(Table 17). 
Soft tissue thickness was increased following use of acellular dermal matrix as a 
barrier membrane (Table 19). 
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Table 21 
Soft Tissue Thickness changes in Ridge Preservation! Augmentation Sites 
Mean ± sd in mm 
StudyNr Tx B 0 L 
Iasella 03 Extr 0.4 0.5 
Vance 04 Calmatrix 0.1 -0.1 
Kirkland 00 Guidor -1.1 -1.5 -0.8 
asella 03 Biomend Ext -0.1 -0.6 
Vance 04 ~ioGide -0.2 0.0 
Cordini ADMg-Block 0.:1 0.5 0.3 
Cordini !ADMg-Flex 0.6 0.0 0.1 
Labey !ADM-Block 0.3 0.8 0.4 
Labey !ADM-Partic 0.6 0.3 0.3 
Adams !ADM-Intra 0.9 0.8 
















Figure 3. c) Parti culate 4 month reentry fac ial; d) Paticulate 4 month reentry occlusal 
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Figure 4. Vital Bone with Non- Vital Block Bone, lOX 
Figure 5. Non-Vital Pati cul ate Bone, and Vital Bone. lOX 
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Figure 6. Mature Vital bone with amorphous organic matrix, lOX 
Figure 7. Vi ta l bone and Vasc ul ar Channels, lOX 
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The Plague Index 
The plaque index of Silness and Loe (1964) will be measured. Scores will be as 
follow: 
0- No plaque 
1 - A film of plaque adhering to the free gingival margin and adjacent area of the tooth. 
The plaque may be seen in situ only after application of disclosing solution or by 
using the probe on the tooth surface. 
2 - Moderate accumulation of soft deposits within the gingival pocket, or on the tooth and 
gingival margin, which can be seen with the naked eye. 
3 - Abundance of soft matter within the gingival pocket and/or on the tooth and gingival 
margm. 
Each gingival unit (buccal, lingual, mesiobuccal, distobuccal, mesiolingual, and 
distolingual) of the individual tooth was given a score from 0-3, called the plaque index 
for the area. The scores from the 6 areas of the tooth were added and divided by 6 to give 




The gingival index of Loe (1967) will be measured for the test and control sites. 
Scores will be recorded as follows: 
0= Normal gingiva. 
1 = Mild inflammation - slight change in color slight edema, no bleeding on probing. 
2 = Moderate inflammation - redness, edema, and glazing, bleeding on probing. 
3 = Severe inflammation - marked redness and edema, ulceration and tendency to 
spontaneous bleeding. 
Each gingival unit (mesiobuccal, buccal, distobuccal, distolingual, lingual, 
mesiolingual) of the tooth will be given a score 0-3. The scores for each unit will be 
added together and divided by 6 to give the gingival index for that tooth. The score of the 
test tooth and the two adjacent teeth will be added and divided by 3 to give the gingival 
index for the test of control sites. 
67 
Appendix C 
Tooth Mobility (Laster et al. 1975) 
A modification of Miller's index was used to measure tooth mobility as suggested by 
Laster et al. 1975. Miller suggested the following scoring system: 
0= Movability of the crown within normal physiologic limits. 
1 = Movability of the crown up to 0.5 mm in one direction. Does not exceed 1.0 mm 
in both directions. 
2 = Movability of the crown from 0.5 to 1 mm in one direction. Does not exceed 2.0 
mm in both directions .. 
3 = Movability of the crown exceeding 1 mm in one direction and/or vertical 
depressibility. Greater than 2.0 mm in both directions and/or vertical 
depressibility. 
The index that was used in the study is a modification of Miller's index (Laster et 




Standardized Radiographic technique 
An occlusal stent was used to provide a stable foundation for the radiograph 
holder. A light cured resin material was placed on a Rinn radiograph holder and 
positioned to allow as near as possible paralleling technique. This material was light 
cured so that standardized radiographs can be compared. Radiographs were taken at 




Ridge width (Post-extraction) = A digital caliper was used to measure total ridge width 
to the nearest 10-2 mm at one point, mid socket, at the alveolar crest and 5 mm 
from the alveolar crest. 
Ridge width (4 month re-entry) = Again, a digital caliper measured total ridge width to 
the nearest 10-2 mm at one point, mid socket, at the alveolar crest and 5 mm from 
the alveolar crest. 
Change in alveolar crest - direct = Initial: stent to alveolar crest minus re-entry stent to 
alveolar crest. 
Alveolar Crest Width = Crestal width was measured with digital calipers during the 
initial surgical appointment and evaluated to determine if a relationship exists 
between ridge width and height and the thickness of the crestal bone. 
Tissue thickness = [Initial: SDM gingival thickness meter 3 mm apical to the soft tissue 
crest on buccal and palatollingual] - [4 month SDM gingival thickness meter 3 
mm apical to the soft tissue crest on buccal and palato/lingual with the addition 




Rigid stents were made of 3 mm thick light cured reSIn material in order to 
provide reproducible measurements. The tooth to be extracted was ground off the model 
and the light cured resin material was pressed over a cast. Three channels were prepared 
on the labial and three on the palatollingual aspect of the stent in which a North Carolina 
periodontal probe was placed so that mesial, mid and distal measurements could be made 
on the labial and palato/lingual aspects of the crestal bone. Additionally, two channels 
were also prepared on the occlusal portion of the stent to provide measures of mesial and 
distal occlusal ridge height. Holes were prepared with a high-speed hand-piece. In this 




Ten serial sections from each study subject were stained and made available for 
histologic analysis. Three slides and two fields per slide (6 fields in total) will be 
randomly selected from to evaluate the percent vital bone, percent non-vital bone, percent 
trabecular space, and number of osteoblasts using a reticle (with a 10 X 10 boxed field) at 
a power of 150X. A box is to be counted as containing a specific histologic tissue if it 
was filled 90% or more by the respective tissue. The mean percentages of the various 
histologic components will be tabulated and reported as mean percentages. 
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Appendix H 
Soft Tissue Thickness Measurements 
Soft tissue measurements were taken at three positions. The first was on the 
buccal 3 mm apical to the soft tissue crest. The second was on the occlusal mid crestally. 
The third was on the lingual 3 mm apical to the soft tissue crest. The measurements were 
taken at initial and reentry appointments. 
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